210 related articles for article (PubMed ID: 11157023)
1. Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.
Ansell SM; Stenson M; Habermann TM; Jelinek DF; Witzig TE
J Clin Oncol; 2001 Feb; 19(3):720-6. PubMed ID: 11157023
[TBL] [Abstract][Full Text] [Related]
2. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
List AF; Spier CM; Miller TP; Grogan TM
Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas.
Muris JJ; Meijer CJ; Cillessen SA; Vos W; Kummer JA; Bladergroen BA; Bogman MJ; MacKenzie MA; Jiwa NM; Siegenbeek van Heukelom LH; Ossenkoppele GJ; Oudejans JJ
Leukemia; 2004 Mar; 18(3):589-96. PubMed ID: 14712286
[TBL] [Abstract][Full Text] [Related]
4. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study.
Hutchison RE; Berard CW; Shuster JJ; Link MP; Pick TE; Murphy SB
J Clin Oncol; 1995 Aug; 13(8):2023-32. PubMed ID: 7636544
[TBL] [Abstract][Full Text] [Related]
5. CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy.
Keane C; Gill D; Vari F; Cross D; Griffiths L; Gandhi M
Am J Hematol; 2013 Apr; 88(4):273-6. PubMed ID: 23460351
[TBL] [Abstract][Full Text] [Related]
6. Host tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas.
Diaz JI; Edinger MG; Stoler M; Tubbs RR
Leuk Lymphoma; 1993 Jan; 9(1-2):85-90. PubMed ID: 8477206
[TBL] [Abstract][Full Text] [Related]
7. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
8. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of T cell subsets in peripheral blood of B cell non-Hodgkin's lymphoma patients.
Dehghani M; Sharifpour S; Amirghofran Z; Zare HR
Med Oncol; 2012 Dec; 29(4):2364-71. PubMed ID: 22307765
[TBL] [Abstract][Full Text] [Related]
10. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
Wu D; Thomas A; Fromm JR
Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
[TBL] [Abstract][Full Text] [Related]
11. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study.
Xu Y; Kroft SH; McKenna RW; Aquino DB
Br J Haematol; 2001 Mar; 112(4):945-9. PubMed ID: 11298589
[TBL] [Abstract][Full Text] [Related]
13. [CD4+CD25+T regulatory cells in peripheral blood of B-NHL patients with or without chemotherapy].
Shi YX; Zhang XS; Liu DG; Li YQ; Guan ZZ; Jiang WQ
Ai Zheng; 2004 May; 23(5):597-601. PubMed ID: 15142463
[TBL] [Abstract][Full Text] [Related]
14. Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B-cell lymphoma.
Higashi M; Tokuhira M; Fujino S; Yamashita T; Abe K; Arai E; Kizaki M; Tamaru J
Leuk Lymphoma; 2016; 57(1):161-6. PubMed ID: 25860238
[TBL] [Abstract][Full Text] [Related]
15. T-cell-rich B-cell lymphoma - diagnostic and therapeutic aspects.
Axdorph U; Porwit-Macdonald A; Sjøberg J; Grimfors G; Bjørkholm M
APMIS; 2002 May; 110(5):379-90. PubMed ID: 12076255
[TBL] [Abstract][Full Text] [Related]
16. [Distribution of CD8+CD28- T cells and CD3+CD56+ NKT cells in peripheral blood of patients with B-cell non-Hodgkin's lymphoma].
Shi YX; Zhang XS; Liu DG; Guan ZZ; Jiang WQ
Ai Zheng; 2004 Nov; 23(11 Suppl):1437-42. PubMed ID: 15566652
[TBL] [Abstract][Full Text] [Related]
17. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
Seidemann K; Tiemann M; Lauterbach I; Mann G; Simonitsch I; Stankewitz K; Schrappe M; Zimmermann M; Niemeyer C; Parwaresch R; Riehm H; Reiter A;
J Clin Oncol; 2003 May; 21(9):1782-9. PubMed ID: 12721255
[TBL] [Abstract][Full Text] [Related]
18. Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma.
Fozza C; Corda G; Virdis P; Contini S; Barraqueddu F; Galleu A; Isoni A; Cossu A; Dore F; Careddu MG; Bonfigli S; Giannico B; Longinotti M
Eur J Haematol; 2015 Apr; 94(4):298-309. PubMed ID: 25040028
[TBL] [Abstract][Full Text] [Related]
19. Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status.
Atanackovic D; Panse J; Schafhausen P; Faltz C; Bartels K; Boeters I; Hossfeld DK; Hegewisch-Becker S
Leuk Res; 2005 Sep; 29(9):1019-27. PubMed ID: 16038728
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
